Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Black Diamond Therapeutics (BDTX) Accumulated Depreciation & Amortization (2018 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Accumulated Depreciation & Amortization for 3 consecutive years, with $246000.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Accumulated Depreciation & Amortization rose 65.1% year-over-year to $246000.0, compared with a TTM value of $246000.0 through Sep 2021, up 65.1%, and an annual FY2020 reading of $164000.0, up 46.43% over the prior year.
  • Accumulated Depreciation & Amortization was $246000.0 for Q3 2021 at Black Diamond Therapeutics, up from $203000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $246000.0 in Q3 2021 and bottomed at $112000.0 in Q4 2019.
  • Average Accumulated Depreciation & Amortization over 3 years is $170285.7, with a median of $164000.0 recorded in 2020.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 46.43% in 2020, then surged 65.1% in 2021.
  • Year by year, Accumulated Depreciation & Amortization stood at $112000.0 in 2019, then soared by 46.43% to $164000.0 in 2020, then soared by 50.0% to $246000.0 in 2021.
  • Business Quant data shows Accumulated Depreciation & Amortization for BDTX at $246000.0 in Q3 2021, $203000.0 in Q2 2021, and $183000.0 in Q1 2021.